An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

por Saavedra, Danay, Añé-Kourí, Ana Laura, Sánchez, Naivy, Filgueira, Lázaro Manuel, Betancourt, Julio, Herrera, Carlos, Manso, Leniel, Chávez, Elibet, Caballero, Armando, Hidalgo, Carlos, Lorenzo, Geydi, Cepeda, Meylan, Valenzuela, Carmen, Ramos, Mayra, León, Kalet, Mazorra, Zaima, Crombet, Tania
Publicado 2020

Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab

por Caballero, Armando, Filgueira, Lázaro M, Betancourt, Julio, Sánchez, Naivy, Hidalgo, Carlos, Ramírez, Alberto, Martinez, Alejandro, Despaigne, Rolando E, Escalona, Alberto, Diaz, Henrry, Meriño, Elio, Ortega, Lilia M, Castillo, Ulises, Ramos, Mayra, Saavedra, Danay, García, Yanelda, Lorenzo, Geydi, Cepeda, Meylán, Arencibia, Maylén, Cabrera, Leticia, Domecq, Milagros, Estévez, Daymys, Valenzuela, Carmen, Lorenzo, Patricia, Sánchez, Lizet, Mazorra, Zaima, León, Kalet, Crombet, Tania
Publicado 2020